Hale Göksever ÇELİK, Damla SAKAR, Alara AK, Faruk BUYRU
Comprehensive Medicine - 2026;18(1):101-103
We present a 31-year-old patient who underwent hysteroscopic myomectomy following gonadotropin-releasing hormone agonist treatment due to inaccessible submucous myomas. At the first operation, 15 fibroids and one endometrioma in the right ovary were removed. Hysteroscopy was not performed to remove these submucous fibroids, as all of them covered the uterine cavity, and if they were removed, the walls of the uterine cavity would adhere, resulting in Asherman syndrome. Following laparoscopic myomectomy, the patient was started on leuprolide treatment, a gonadotropin-releasing hormone agonist, for two months. Then hysteroscopy was conducted, and it was observed that all submucous fibroids had undergone significant degeneration, with reduction in size, softening, and could be easily excised.
